Tuberculosis Vaccine Market Trends, Segmentation, Growth, Analysis and Forecast 2022-2028

The global tuberculosis vaccine market is anticipated to grow at a CAGR of 8.4% during the forecast period. Tuberculosis vaccine such as BCG (stands for Bacille Calmette-Guérin) is the most widely used tuberculosis vaccine and are being commercialized for the prevention of tuberculosis. Various advancements in the areas of mycobacterial immunology and genomics have fueled the research on multiple new experimental vaccines that is the key factor driving the market growth. In addition to this, the relatively low cost of these vaccines, as well as the easy availability of the vaccine are the major drivers of the industry growth. With an increase in the number of tuberculosis cases globally, the demand for tuberculosis vaccines is projected to increase more, thereby driving the market growth. As per WHO, a total of 1.5 million people died from TB in 2020 (including 214 000 people with HIV). In the same year, 1.1 million children fell ill with TB globally. TB is the 13th leading cause of death and the second leading infectious killer after COVID-19. 

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/tuberculosis-vaccine-market

Moreover, the growth in the technological advancements for vaccine research, rising government initiatives, and emphasis on immunization programs all over the globe will also boost the market growth during the forecast period. However, the side effect such as high temperature, headache, swollen glands under the armpit, and soreness or discharge where the injection was given, associated with the vaccine may act as restrain the further growth of the market. 

Tuberculosis Vaccine Market- Segmentation

By Type

• Immunotherapeutic Vaccine
• Booster Vaccine

By End-User

• Hospitals
• Clinics
• Others

A full report of Tuberculosis Vaccine Market is available at: https://www.omrglobal.com/industry-reports/tuberculosis-vaccine-market

Tuberculosis Vaccine Market– Segment by Region

North America          

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific   

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• AJ Vaccines A/S
• China National Pharmaceutical Group Corp
• Dr. Reddy’s Laboratories Ltd.
• GlaxoSmithKline PLC
• GreenSignal Bio Pharma Pvt. Ltd. 
• InterVax Ltd.
• Japan BCG Laboratory
• Merck & Co. Inc.
• Pfizer Inc.
• Sanofi SA
• Serum Institute of India Ltd.
• Statens Serum Institut
• Taj Pharmaceuticals Ltd.

Reasons to Buying From us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Contact Person: Mr. Anurag Tiwari

Email: anurag@omrglobal.com

Contact no: +91 780-304-0404

Company Name: Orion Market Research

Article source: https://article-realm.com/article/Sports-Recreation/32946-Tuberculosis-Vaccine-Market-Trends-Segmentation-Growth-Analysis-and-Forecast-2022-2028.html